相关实验视频

Updated: Jul 15, 2025

Recombinant Retroviral Production and Infection of B Cells

Recombinant Retroviral Production and Infection of B Cells

Published on: February 18, 2011

在自身免疫性疾病中治疗rituximab后的B细胞重组轨迹:一项纵向观察性研究

Yuxue Nie¹, Jingna Li¹, Di Wu¹

¹Department of Rheumatology, National Clinical Research Center for Dermatologic and Immunologic Diseases, State Key Laboratory of Complex Severe and Rare Diseases, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.

Clinical and experimental medicine

|September 26, 2023

概括

针对自身免疫性疾病的瑞图西马布治疗显示出不同的B细胞恢复. 诸如IgA水平和葡萄糖皮质激素使用等因素影响B细胞重组,一些患者经历了长期的B细胞枯竭.

科学领域:

免疫学免疫学免疫学
类风湿病学类风湿病学
药理学药理学是指药理学的学科.

背景情况:

利图西马布 (RTX) 是对自身免疫性疾病 (AIDs) 的关键疗法.
了解RTX后的B细胞重组动态对于优化治疗策略至关重要.
特定于患者的因素可能会影响B细胞恢复的轨迹.

研究的目的:

为了研究用RTX治疗的AID患者的纵向B细胞重定位模式.
为了确定与B细胞重组相关的临床和实验室因素.
用潜阶级轨迹建模来描述不同的B细胞恢复轨迹.

主要方法:

对224名接受RTX的艾滋病患者进行了回顾性研究.
卡普兰-梅尔分析和考克斯回归用于因子关联.
隐性类轨迹建模 (LCTM) 用于纵向B细胞恢复模式.

主要成果:

在不同的AID (例如,AAV,CTD,IgG4-RD) 中,B细胞重新填充的时间有显著差异.
较高的IgA水平和同时使用葡萄糖皮质激素与更快的B细胞重组有关.
LCTM确定了一个B细胞耗尽时间长的集群,其特点是特定的人口,疾病和治疗因素.

结论:

在AIDs中RTX后B细胞的重新填充是异质的.
B细胞恢复的预测因素包括IgA水平和葡萄糖皮质体剂的使用.
一部分患者表现出长期的B细胞枯竭,需要进一步调查和量身定制的治疗.

关键词:

自身免疫性疾病是一种自身免疫性疾病.B细胞是B细胞的组成部分.里图西马布 (Rituximab) 是一种药物.飞行轨迹的轨迹是可以的.

更多相关视频

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies

Published on: May 22, 2020

Retroviral Overexpression of CXCR4 on Murine B-1a Cells and Adoptive Transfer for Targeted B-1a Cell Migration to the Bone Marrow and IgM Production

Retroviral Overexpression of CXCR4 on Murine B-1a Cells and Adoptive Transfer for Targeted B-1a Cell Migration to the Bone Marrow and IgM Production

Published on: May 31, 2020

相关概念视频

B Cell Activation and Differentiation

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...

Cells of the Adaptive Immune Response

Cells of the Adaptive Immune Response

The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...